Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Aaron Sasson
Individual Investor

Aaron Sasson

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Exits 
Unlock for free
  • Primary Job Title Member of the Board of Directors
  • Primary Organization 
    BioSight Logo
    BioSight
  • Investor Type 
    obfuscation
  • Number of Exits 
    obfuscation
Aaron Sasson is the Member of the Board of Directors of BioSight.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Aaron Sasson invested in ClearMetal on
obfuscation
. This investment - Series A - ClearMetal - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
ClearMetal Logo
ClearMetal
—
Series A - ClearMetal Logo
Series A - ClearMetal
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
Aaron Sasson has
obfuscation
exit - ClearMetal. Aaron Sasson has
obfuscation
exits. Their most notable exits are ClearMetal.
  • ClearMetal Logo
    ClearMetal Leading Supply Chain & Logistics Solution Utilizing Continuous Delivery Experience (CDX)

Jobs

Edit Jobs Section
Number of Current Jobs 3
Aaron Sasson has 3 current jobs including Executive Chairman at Winmore, Member of the Board of Directors at BioSight, and General Partner at Primera Capital.

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 3
Number of Past Board & Advisor Roles 2
Aaron Sasson holds 3 board and advisor roles including Member of the Board of Directors at BioSight, Board of Directors at Conquer Cancer Foundation, and Advisor at Phluence.
Organization Name  
Title At Company  
Start Date  
End Date  
Lanetix Logo
Lanetix
Co-Founder & Chairman of the BoardJul 2013Dec 2018
GT Nexus Logo
GT Nexus
Chairman and co-founder1998Sep 2015

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Acquired Pharmaceutical Companies Logo
Acquired Pharmaceutical Companies
4,793
Therapeutics Companies that Exited Logo
Therapeutics Companies that Exited
12,572
Phoenix Financial Portfolio Companies Logo
Phoenix Financial Portfolio Companies
88,183
Acquired Therapeutics Companies Logo
Acquired Therapeutics Companies
25,882
Acquired Biotechnology Companies Logo
Acquired Biotechnology Companies
4,200
Closed Pharmaceutical Companies Logo
Closed Pharmaceutical Companies
27,816
Acquired Health Care Companies (Top 10K) Logo
Acquired Health Care Companies (Top 10K)
647
Closed Biotechnology Companies Logo
Closed Biotechnology Companies
15,037
Trendlines Group Portfolio Companies Logo
Trendlines Group Portfolio Companies
79,851
Companies That Exited in 2023 (Top 10K) Logo
Companies That Exited in 2023 (Top 10K)
600

Education

Edit Education Section
Aaron Sasson studied at University College London (UCL).

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 1
Funding Round•Feb 4, 2020
ClearMetal raised
obfuscation
from Aaron Sasson and 13 other investors
Discover more funding rounds
News•Dec 4, 2000
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(fe3140e 1)
|